Hugo™ Robotic Assisted Surgery (RAS) System in Prostatectomy Patients Treated in an ASC Setting
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Central Ohio Urology Group
- Study ID
- NCT07875192
- Status
- Recruiting
Conditions
- Prostate Cancer (Diagnosis)
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
A Single-center Study of Robotic Prostatectomy Surgeries Performed using the Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in an Ambulatory Surgical Center Setting
Key Dates
- First listed
- Oct 15, 2026
- Start date
- Sep 30, 2026
- Status verified
- Oct 2026
- Primary completion
- Sep 30, 2028
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 100 participants (estimated)
Primary Outcome Measure
Incidence of Perioperative Complications [ Time Frame: From first incision through skin closure ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Central Ohio Urology Group | Columbus | Ohio | 43230 |
Find similar trials in Columbus, OH
By research site
Related Studies
- Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617PHASE1 · Recruiting · Thomas Hope · San Francisco, California
- PSMA PET for Surveillance After Focal TherapyRecruiting · University of Chicago · Chicago, Illinois
- Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate CancerRecruiting · Duke University · Durham, North Carolina
- High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)PHASE2 · Recruiting · Cedars-Sinai Medical Center · Los Angeles, California